Patients / advocates

HER2-Mutant Lung Cancer Just Moved Into First Line

One Psychedelic Dose Is Now a Phase III Argument

Cancer Screening Is Still Designed for the Able-Bodied Patient

MOGAD Is Close to Its First Real Treatment

Breast Cancer Just Proved Why Biomarker Selection Matters

Menstrual Migraine Was Never Just Regular Migraine

Brain Cancer Finally Gets the PET Scan It Has Been Missing

Epilepsy Innovation Just Hit a Safety Wall

The Thymus May Be the Organ Radiation Oncology Forgot
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
